Strategic Wealth Partners’s Biogen BIIB Stock Holding History

Strategic Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.1K	Buy	107 +2	+2%	+$383	﹤0.01%	711
2026 Q1	$19.3K	Hold	105	–	–	﹤0.01%	714
2025 Q4	$18.5K	Hold	105	–	–	﹤0.01%	719
2025 Q3	$14.7K	Sell	105 -175	-63%	-$23.7K	﹤0.01%	810
2025 Q2	$35.2K	Buy	+280	New	+$34.9K	﹤0.01%	557
2023 Q4	–	Sell	-3,376	Closed	-$868K	–	279
2023 Q3	$868K	Sell	3,376 -445	-12%	-$119K	0.11%	164
2023 Q2	$1.09M	Sell	3,821 -65	-2%	-$19.3K	0.14%	150
2023 Q1	$1.08M	Sell	3,886 -361	-9%	-$99.9K	0.17%	127
2022 Q4	$1.18M	Sell	4,247 -499	-11%	-$141K	0.22%	112
2022 Q3	$1.27M	Sell	4,746 -8,314	-64%	-$1.77M	0.27%	110
2022 Q2	$2.66M	Sell	13,060 -346	-3%	-$70.7K	0.58%	56
2022 Q1	$2.82M	Buy	13,406 +381	+3%	+$82.9K	0.55%	55
2021 Q4	$3.13M	Buy	+13,025	New	+$3.35M	0.59%	51
2019 Q4	–	Sell	-150	Closed	-$34.9K	–	167
2019 Q3	$34.9K	Hold	150	–	–	0.18%	97
2019 Q2	$35K	Hold	150	–	–	0.02%	265
2019 Q1	$35K	Buy	+150	New	+$47.2K	0.02%	278
2018 Q2	–	Sell	-34	Closed	-$9K	–	755
2018 Q1	$9K	Hold	34	–	–	﹤0.01%	567
2017 Q4	$11K	Buy	+34	New	+$10.9K	0.01%	484

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Strategic Wealth Partners's BIIB Position: Q2 2026 in Review

Strategic Wealth Partners increased its Biogen (BIIB) stake by 1.9% in Q2 2026, buying an estimated $383 and bringing the position to 107 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #711.

Strategic Wealth Partners first reported a position in BIIB in Q4 2017 and has held it in 18 quarters since. The position peaked at $3.13M in Q4 2021. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Strategic Wealth Partners held 107 shares of Biogen worth $23.1K as of Q2 2026.
Strategic Wealth Partners bought 2 Biogen shares in Q2 2026, an estimated $383.
Biogen made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q2 2026, its #711 holding.
Strategic Wealth Partners first reported a position in Biogen in Q4 2017 and has held it in 18 quarters since.
Strategic Wealth Partners's Biogen position peaked at $3.13M in Q4 2021.
1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Strategic Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.